Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 8.1B | 7.7B | 11.1B |
Cost of revenue | 5.4B | 4.7B | 4.6B | 6.5B |
Gross profit | 3.9B | 3.4B | 3.2B | 4.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.4B | 2.1B | 2.3B | 2.4B |
Operating income | -132.7M | -374.4M | -768.3M | 331.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 165.7M | 173.8M | 174M | 168.9M |
Other income expense | — | — | — | — |
Pretax income | -198.1M | -511M | 62.4M | 212.2M |
Tax provision | 49M | -156.2M | -84.3M | 86M |
Net income | -247.1M | -354.8M | 146.7M | 126.2M |
Basic EPS | — | -47.1 | 19.5 | 16.7 |
Diluted EPS | — | -47.1 | 19.5 | 16.7 |
Basic average shares | — | 7.5M | 7.5M | 7.5M |
Diluted average shares | — | 7.5M | 7.5M | 7.5M |
EBITDA | 324.5M | 30.8M | -224.9M | 739.4M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |